CG Oncology, Inc. Common stock Net Asset Quality Index
CG Oncology, Inc. Common stock net asset quality index. CG Oncology, Inc. Common stock (CGON) has a Net Asset Quality Index of 95.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $791.59 Million minus total liabilities of $38.99 Million yields net assets of $752.60 Million. A higher index indicates a stronger, lower-leverage balance sheet. See CG Oncology, Inc. Common stock (CGON) shareholders funds for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of CG Oncology, Inc. Common stock (2021–2025)
Net asset quality index of CG Oncology, Inc. Common stock from 2021 to 2025. This chart shows how CG Oncology, Inc. Common stock's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 95.1%, representing net assets of $752.60 Million against total assets of $791.59 Million USD. Check CG Oncology, Inc. Common stock (CGON) tangible equity ratio to evaluate the tangible quality of the company's equity base.
CG Oncology, Inc. Common stock Net Asset Quality Index by Year (2021–2025)
CG Oncology, Inc. Common stock net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for CG Oncology, Inc. Common stock from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CG Oncology, Inc. Common stock (CGON) total market value.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.1% | $752.60 Million | $791.59 Million | $38.99 Million | ▼ -2.1 pp |
| 2024 | 97.2% | $733.38 Million | $754.80 Million | $21.42 Million | ▲ +4.4 pp |
| 2023 | 92.7% | $184.79 Million | $199.30 Million | $14.51 Million | ▲ +8.0 pp |
| 2022 | 84.7% | $125.18 Million | $147.75 Million | $22.57 Million | ▲ +16.1 pp |
| 2021 | 68.6% | $40.25 Million | $58.69 Million | $18.44 Million | — |